TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Novartis ( (NVS) ) has issued an announcement.
On November 20, 2025, Novartis announced an updated sales growth forecast for 2025-2030, projecting a compound annual growth rate (CAGR) of 5-6%. The company has upgraded its peak sales guidance for key products like Kisqali and Scemblix, reflecting strong momentum from in-market growth drivers and upcoming product launches. Novartis is entering a catalyst-rich period with over 15 potential submission-enabling readouts expected in the next two years, supported by a pipeline of more than 30 potential high-value medicines. The company’s strategic acquisitions, including the planned acquisition of Avidity Biosciences, are expected to bolster its pipeline and strengthen its market position, ensuring continued growth beyond 2030.
The most recent analyst rating on (NVS) stock is a Buy with a $151.00 price target. To see the full list of analyst forecasts on Novartis stock, see the NVS Stock Forecast page.
Spark’s Take on NVS Stock
According to Spark, TipRanks’ AI Analyst, NVS is a Outperform.
Novartis presents a strong investment case with robust financial performance and positive earnings call highlights. The technical analysis supports a positive trend, though valuation metrics are moderate. The company’s strategic focus on innovation and expansion, despite some market challenges, underpins its growth potential.
To see Spark’s full report on NVS stock, click here.
More about Novartis
Novartis AG is a leading global healthcare company based in Switzerland, primarily focused on the development and commercialization of innovative medicines. The company operates in the pharmaceutical industry and has a robust pipeline of high-value medicines across core therapeutic areas, aiming to drive long-term sustainable growth.
Average Trading Volume: 1,478,428
Technical Sentiment Signal: Buy
Current Market Cap: $241.2B
Learn more about NVS stock on TipRanks’ Stock Analysis page.